IDRA 21
CAS: 22503-72-6
Ref. 3D-XAA50372
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
IDRA 21
Sinónimos:
- 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide
- 7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
- 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-S,S-dioxide
- Idra 21
Descrição:
IDRA 21 is a synthetic analog of the neurotransmitter gamma-aminobutyric acid (GABA) that acts as an agonist at GABA receptors to inhibit neuronal activity. IDRA 21 has been shown to have desensitizing effects on GABA receptors, which may be due to its ability to increase cyclothiazide levels by hydrogen bonding. This drug also enhances the effects of acetylcholine in the brain and can be used for experimental models of Parkinson's disease. The structural analysis of IDRA 21 shows that it binds with nitrogen atoms in a way that is similar to glutamate, which is a neurotransmitter implicated in the development of epilepsy. IDRA 21 has been shown to inhibit neuronal death and promote nerve regeneration in rat granule neurons.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
232.69 g/mol
Fórmula:
C8H9ClN2O2S
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
